Stay updated on Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page shows the CheckMate 143 clinical trial record for nivolumab and bevacizumab in glioblastoma, with study details, results measures, eligibility criteria, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-08T04:55:14.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-01T02:06:17.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A sitewide announcement says NIH websites are transitioning and explains that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T02:04:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:48:14.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:18:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden screen with a minimal header and a Home link, replacing the previous study record content. This indicates an access restriction rather than an update to the study information.
    Difference
    18%
    Check dated 2026-09-20T01:18:14.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.